V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 10002755 | 10006270 | 1.7 | 77.2 | Neo-adjuvant (N) | 2017-11-08 | 2017-11-24 | ECX | 02 | N | 10445619 | ECX |
| 10002756 | 10006270 | 1.81 | 81.6 | Palliative (P) | 2017-03-18 | 2017-04-01 | GEMCITABINE | 2 | N | 10445619 | GEMCITABINE |
| 10002757 | 10006270 | 1.53 | null | Palliative (P) | 2013-05-20 | 2013-05-22 | Cisplatin + Pemetrexed | N | N | 10445619 | CISPLATIN + PEMETREXED |
| 10002758 | 10006270 | 1.65 | 46.3 | Palliative (P) | null | 2014-05-02 | Gemcitabine weekly | 02 | N | 10445619 | GEMCITABINE |
| 10002759 | 10001801 | 1.66 | 76 | Palliative (P) | 2011-01-12 | 2015-02-04 | PEMBROLIZUMAB | 2 | N | 10445890 | PEMBROLIZUMAB |
| 10002760 | 10001802 | 1.73 | 98.4 | Curative (C) | 2012-12-10 | 2018-09-01 | CVP R | null | N | 10445918 | CVP R |
| 10002761 | 10001802 | 1.73 | 0 | Palliative (P) | 2017-01-30 | 2017-01-30 | Cisplatin + Pemetrexed | 02 | N | 10445918 | CISPLATIN + PEMETREXED |
| 10002762 | 10001803 | 1.65 | null | Palliative (P) | 2017-06-19 | 2017-06-19 | Hydroxycarbamide | N | N | 10445946 | HYDROXYCARBAMIDE |
| 10002763 | 10001804 | 1.78 | 64 | Palliative (P) | 2018-10-25 | 2018-10-25 | Enzalutamide | null | N | 10445974 | ENZALUTAMIDE |
| 10002764 | 10001805 | null | 93 | Palliative (P) | 2018-05-06 | 2018-06-01 | Enzalutamide | N | N | 10445977 | ENZALUTAMIDE |
| 10002765 | 10001806 | 1.72 | 92 | Palliative (P) | 2015-05-06 | 2015-05-12 | Cisplatin + Pemetrexed | N | N | 10446004 | CISPLATIN + PEMETREXED |
| 10002766 | 10001806 | 0.72 | 80.6 | Neo-adjuvant (N) | 2018-05-17 | 2018-05-17 | ECX | N | null | 10446004 | ECX |
| 10002767 | 10001807 | 1.82 | 81.6 | Disease modification (D) | 2018-01-24 | 2018-01-25 | Hydroxycarbamide | N | N | 10446241 | HYDROXYCARBAMIDE |
| 10002768 | 10001808 | null | 85 | Palliative (P) | 2017-02-21 | 2017-02-24 | Hydroxycarbamide | null | N | 10446274 | HYDROXYCARBAMIDE |
| 10002769 | 10001808 | 1.77 | 103.2 | Palliative (P) | 2018-04-14 | 2018-04-14 | ECX | 02 | N | 10446274 | ECX |
| 10002770 | 10001809 | 0 | 56.3 | null | 2018-02-02 | 2018-02-03 | Trial Unspecified | 01 | null | 10446312 | TRIAL |
| 10002771 | 10001810 | 0 | 107 | Palliative (P) | 2016-07-31 | 2016-08-12 | GEMCITABINE | N | N | 10446319 | GEMCITABINE |
| 10002772 | 10006274 | 1.61 | null | Palliative (P) | 2018-11-03 | 2018-11-06 | Enzalutamide | N | N | 10446328 | ENZALUTAMIDE |
| 10002773 | 10001811 | 0 | 86 | Palliative (P) | 2016-03-18 | 2016-03-18 | Cisplatin + Pemetrexed | N | N | 10446355 | CISPLATIN + PEMETREXED |
| 10002774 | 10001811 | 1.74 | 77.9 | Neo-adjuvant (N) | 2015-04-06 | 2015-04-13 | ECX | N | N | 10446355 | ECX |
| 10002775 | 10001811 | 1.69 | 83.7 | Palliative (P) | 2014-12-30 | 2015-01-07 | ECX | N | N | 10446355 | ECX |
| 10002776 | 10001812 | 1.64 | 86.35 | Palliative (P) | 2016-12-07 | 2016-12-12 | PEMBROLIZUMAB | N | Y | 10446710 | PEMBROLIZUMAB |
| 10002777 | 10001812 | 1.65 | 75.6 | Palliative (P) | 2016-03-13 | 2016-04-04 | Cisplatin + Pemetrexed | N | Y | 10446710 | CISPLATIN + PEMETREXED |
| 10002778 | 10001812 | 1.65 | 76 | Palliative (P) | null | 2018-06-25 | Carboplatin + Vinorelbine IV &PO D8 | N | N | 10446710 | CARBOPLATIN + VINORELBINE |
| 10002779 | 10001813 | 1.8 | 81 | Curative (C) | 2014-11-19 | 2014-11-25 | CVP R | N | N | 10446829 | CVP R |
| 10002780 | 10001814 | 1.83 | 81.5 | Adjuvant (A) | 2015-05-15 | 2015-05-21 | Carboplatin + Vinorelbine Oral | N | N | 10446896 | CARBOPLATIN + VINORELBINE |
| 10002781 | 10001814 | 1.55 | 60 | Palliative (P) | 2013-11-23 | 2013-11-23 | Hydroxycarbamide | 02 | N | 10446896 | HYDROXYCARBAMIDE |
| 10002782 | 10001814 | 1.62 | null | Palliative (P) | 2016-08-30 | 2016-09-12 | Rituximab | 2 | N | 10446896 | RITUXIMAB |
| 10002783 | 10001814 | 1.76 | 0 | Palliative (P) | 2015-11-21 | 2015-12-07 | GEMCITABINE | N | N | 10446896 | GEMCITABINE |
| 10002784 | 10001814 | 1.81 | 68 | Palliative (P) | 2018-03-02 | 2018-03-15 | PEMBROLIZUMAB | 02 | N | 10446896 | PEMBROLIZUMAB |
| 10002785 | 10009216 | 1.63 | null | Palliative (P) | 2014-08-25 | 2014-08-25 | Rituximab (Maintenance) | 02 | N | 10447211 | RITUXIMAB |
| 10002786 | 10009216 | 1.65 | 76 | Palliative (P) | 2016-06-20 | 2016-06-20 | Enzalutamide | N | N | 10447211 | ENZALUTAMIDE |
| 10002787 | 10009295 | 1.76 | 62 | Palliative (P) | 2017-02-13 | 2017-02-13 | CVP R | 02 | N | 10447288 | CVP R |
| 10002788 | 10001815 | 1.63 | null | Palliative (P) | 2015-07-20 | 2015-07-31 | EOX | 02 | N | 10447339 | EOX |
| 10002789 | 10001816 | 1.7 | 90.7 | Palliative (P) | 2018-01-13 | 2018-01-23 | Gemcitabine weekly | N | null | 10447385 | GEMCITABINE |
| 10002790 | 10001816 | 1.7 | 71.1 | Curative (C) | 2016-01-15 | 2016-01-16 | Hydroxycarbamide | 02 | N | 10447385 | HYDROXYCARBAMIDE |
| 10002791 | 10001816 | 1.68 | 70 | Curative (C) | 2018-07-27 | 2018-07-28 | CVP R | 02 | N | 10447385 | CVP R |
| 10002792 | 10001817 | 1.73 | 39.7 | null | 2017-04-26 | 2017-05-03 | Rituximab | Y | N | 10447433 | RITUXIMAB |
| 10002793 | 10001818 | null | null | Radical (R) | 2017-04-12 | 2017-05-10 | Rituximab | N | null | 10447448 | RITUXIMAB |
| 10002794 | 10001819 | 1.67 | 63.9 | Adjuvant (A) | 2018-08-12 | 2018-08-13 | CISPLATIN + VINORELBINE | 02 | N | 10447628 | CISPLATIN + VINORELBINE |
| 10002795 | 10001820 | 1.73 | 73.6 | Disease modification (D) | 2014-08-26 | 2014-09-09 | CVP R | N | N | 10447647 | CVP R |
| 10002796 | 10001821 | 1.85 | 102.2 | Palliative (P) | null | 2018-10-31 | Hydroxycarbamide | N | N | 10447679 | HYDROXYCARBAMIDE |
| 10002797 | 10001821 | 1.48 | 57 | Palliative (P) | 2017-12-15 | 2017-12-16 | PEMBROLIZUMAB | 01 | N | 10447679 | PEMBROLIZUMAB |
| 10002798 | 10001821 | 1.51 | 89.9 | Palliative (P) | 2015-03-23 | 2015-03-28 | Rituximab | N | null | 10447679 | RITUXIMAB |
| 10002799 | 10001821 | 1.84 | 67 | Palliative (P) | 2017-10-31 | 2017-11-01 | PEMBROLIZUMAB | 02 | N | 10447679 | PEMBROLIZUMAB |
| 10002800 | 10001822 | 1.86 | 74.1 | Palliative (P) | 2016-05-08 | 2016-05-20 | Gemcitabine 1000mg/m2 D1 8 15 | N | null | 10447840 | GEMCITABINE |
| 10002801 | 10001822 | 1.63 | null | Disease modification (D) | 2017-04-24 | 2017-05-06 | Rituximab (SUBCUTANEOUS Maintenance) | 2 | N | 10447840 | RITUXIMAB |
| 10002802 | 10001823 | 1.6 | 69.2 | Palliative (P) | 2019-06-01 | 2019-07-14 | Cisplatin + Pemetrexed | 2 | null | 10447905 | CISPLATIN + PEMETREXED |
| 10002803 | 10001824 | 1.68 | 70.9 | Adjuvant (A) | 2015-08-24 | 2015-08-24 | Cisplatin + Vinorelbine (PO) | N | N | 10448154 | CISPLATIN + VINORELBINE |
| 10002804 | 10001824 | 1.73 | 97.4 | Curative (C) | 2016-01-05 | 2016-01-26 | Cisplatin + Vinorelbine (IV) | 2 | N | 10448154 | CISPLATIN + VINORELBINE |